Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $113.88 | $26.27 | 333.52% | 214.87x | 54.20x | 14.44x | 17.44x | 1.56x | $106.92M | 0.89% | $705.78M | 6.70 | $12.21B | 1,556.23 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $23.78 | $8.93 | 166.15% | 113.24x | 55.30x | 6.69x | 13.55x | 0.97x | $39.15M | 1.26% | $220.58M | 1.69 | $3.07B | 67.60 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $78.08 | $18.93 | 312.57% | 72.97x | 66.80x | 7.20x | 9.31x | 1.86x | $182.84M | 3.02% | $654.15M | 8.43 | $5.93B | 49.40 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $237.10 | $86.64 | 173.67% | 38.87x | 34.95x | 6.59x | 23.43x | 1.37x | $793.95M | 2.51% | $1.35B | 10.14 | $33.01B | 27.98 | ||
| KRYS | KRYSTAL BIOTECH INC | $351.46 | $92.10 | 281.59% | 42.50x | 45.03x | 23.56x | 7.65x | 2.25x | $257.78M | 2.48% | $1.36B | 46.03 | $9.98B | 42.80 | ||
| HALO | HALOZYME THERAPEUTICS INC | $105.35 | $74.19 | 42.00% | 29.59x | 11.66x | 7.43x | 83.30x | 0.60x | $806.22M | 6.53% | $143.54M | 1.22 | $13.94B | 19.40 | ||
| RPRX | ROYALTY PHARMA PLC | $60.85 | $39.35 | 54.65% | 32.37x | 11.36x | 10.68x | 3.58x | 0.66x | $2.92B | 10.80% | $9.79B | 21.99 | $43.14B | 36.68 | ||
| VCEL | VERICEL CORP | $40.95 | $8.74 | 368.75% | 85.31x | 73.16x | 6.83x | 5.67x | 2.09x | $61.66M | 2.95% | $370.04M | 7.25 | $2.06B | 46.86 | ||
| TGTX | TG THERAPEUTICS INC | $53.93 | $24.50 | 120.14% | 17.51x | 54.27x | 9.56x | 13.67x | 1.95x | $17.39M | 0.23% | $604.08M | 4.26 | $8.52B | 61.23 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.57 | $8.32 | 39.06% | 12.17x | 10.63x | 5.03x | 3.16x | 1.06x | $82.01M | 11.98% | $217.65M | 3.68 | $542.95M | 7.02 | ||
| TECH | BIO-TECHNE CORP | $72.35 | $17.90 | 304.11% | 61.84x | 34.65x | 9.29x | 5.38x | 1.95x | $263.22M | 2.33% | $2.11B | 13.52 | $11.37B | 32.70 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $64.67 | $20.58 | 214.19% | 170.17x | 22.21x | 3.67x | 1.98x | 1.12x | $738.18M | 5.90% | $6.32B | 32.68 | $15.83B | 41.04 | ||
| ADMA | ADMA BIOLOGICS INC | $9.34 | $7.62 | 22.50% | 12.97x | 11.74x | 4.16x | 5.12x | 0.76x | $116.47M | 5.46% | $408.21M | 1.79 | $2.15B | 9.24 | ||
| EXEL | EXELIXIS INC | $54.45 | $32.74 | 66.31% | 16.55x | 16.49x | 5.61x | 7.32x | 1.09x | $1.17B | 8.59% | $1.84B | 7.35 | $13.38B | 12.30 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.20 | $6.49 | -81.52% | 8.57x | -4.06x | 1.48x | 1.58x | 0.07x | $19.58M | 28.17% | $44.20M | 0.76 | $21.15M | 2.77 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $280.49 | $93.90 | 198.70% | 27.85x | 29.69x | 19.37x | 5.78x | 2.11x | $130.62M | 2.32% | $967.52M | 48.22 | $5.72B | 20.49 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $244.54 | $194.50 | 25.73% | 16.02x | 9.57x | 3.36x | 3.31x | 0.67x | $1.62B | 10.48% | $4.80B | 75.98 | $18.65B | 11.54 | ||
| MDXG | MIMEDX GROUP INC | $4.50 | $1.56 | 188.91% | 112.50x | -32.07x | 1.87x | 3.04x | 1.07x | $44.50M | 6.69% | $216.00M | 1.46 | $537.29M | 23.56 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $541.69 | $166.29 | 225.75% | 31.26x | 28.18x | 10.92x | 6.78x | 2.22x | $3.80B | 2.76% | $20.25B | 79.81 | $133.13B | 24.19 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $794.19 | $466.13 | 70.38% | 18.94x | 14.24x | 5.26x | 2.58x | 1.01x | $3.76B | 4.61% | $31.71B | 308.48 | $82.02B | 14.26 | ||
| UTHR | UNITED THERAPEUTICS CORP | $515.46 | $209.34 | 146.23% | 17.05x | 19.24x | 6.96x | 3.45x | 2.95x | $1.09B | 4.98% | $6.40B | 150.24 | $20.31B | 12.11 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.21 | $32.88 | 19.24% | 12.49x | 9.41x | 2.37x | 2.29x | 0.74x | $354.90M | 15.62% | $999.24M | 17.25 | $1.89B | 6.74 | ||
| INCY | INCYTE CORP | $124.37 | $64.37 | 93.21% | 15.32x | 35.08x | 4.28x | 3.97x | 1.72x | $1.92B | 7.71% | $6.34B | 31.66 | $21.26B | 10.28 | ||
| VCYT | VERACYTE INC | $43.34 | $7.40 | 485.71% | 30.10x | 41.45x | 6.17x | 2.51x | 119.71x | $165.99M | 4.79% | $1.39B | 17.36 | $3.22B | 23.07 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.